-
Gefitinib Sensitization of Cisplatin-Resistant NSCLC
2026-09-15
The reference study identifies abnormal EGFR phosphorylation as a potential off-target mechanism of Cisplatin resistance in wild-type EGFR non-small cell lung cancer. Using paired parental and resistant cell models plus H358R xenografts, the authors show that gefitinib can enhance Cisplatin-associated growth suppression and apoptosis, supporting EGFR inhibition as a preclinical combination strategy rather than as mutation-directed monotherapy.
-
Cy5-UTP: From RNA Labeling to XIST–SPEN Mechanism
2026-09-14
Cy5-UTP can do more than make RNA visible. When integrated with the structural biology of XIST A-repeat binding to SPEN, Cyanine 5-uridine triphosphate supports a mechanism-first workflow for RNA probe synthesis, fluorescence in situ hybridization, biochemical validation, and translational assay design.
-
H2S Deficiency and ER Stress in Diabetic Cardiomyopathy
2026-09-14
The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistically relevant feature of lipotoxic injury in diabetic cardiomyopathy. By combining patient samples, a diabetic rat model, and palmitate-treated cardiomyocytes, it links H2S deficiency with endoplasmic reticulum stress and shows that H2S donation can reduce myocardial injury-related phenotypes.
-
How Mixing Shapes mRNA LNP Performance
2026-09-13
This Nature Communications study isolates primary mixing as a major determinant of mRNA lipid nanoparticle physicochemistry and biological performance. By comparing ten mixing approaches under otherwise controlled formulation conditions, it shows why manually prepared or laminar-mixed particles may not predict materials produced with turbulent-flow equipment at manufacturing scale.
-
Ibrutinib (PCI-32765): BTK Research Workflows
2026-09-12
Build reproducible B-cell receptor signaling assays with Ibrutinib (PCI-32765), from acute BTK pathway readouts to longer-term viability studies. The workflow also shows how ATRX-stratified glioma findings can inform experimental design without overstating evidence for BTK inhibition outside B-cell models.
-
Selonsertib (GS-4997) in Kidney Fibrosis Workflows
2026-09-12
Selonsertib (GS-4997) provides a selective way to test whether ASK1-driven oxidative stress contributes to renal inflammation and tubulointerstitial fibrosis. This practical guide connects the lupus nephritis reference model with cell-based pathway assays, formulation controls, and decision points for diabetic kidney disease research.
-
Fructus Rubi Glycosides in Benign Prostatic Hyperplasia
2026-09-11
The reference study evaluates a diterpene glycoside extract from Fructus Rubi as a multitarget intervention for benign prostatic hyperplasia, combining androgen-pathway modulation with effects on TGF-β/Smad-associated remodeling. Its integrated cell, rat, and target-stability design provides a mechanistic framework for interpreting how botanical constituents may reduce prostate-cell proliferation and pathological enlargement.
-
Silybin A in Metabolic Liver Research
2026-09-11
Silybin A offers a defined chemical tool for studying oxidative stress, inflammation, and hepatoprotective signaling. This article connects Silymarin research with adipose-targeted CRISPRi while providing an assay framework that separates genetic causality from small-molecule response.
-
Biomimetic Chromatography for Lung Permeability
2026-09-10
Dillon and colleagues evaluate mass spectrometry-compatible immobilised artificial membrane liquid chromatography and open-tubular capillary electrochromatography as biomimetic tools for modelling pulmonary drug permeability. Their results show that IAM-LC provides a useful permeability-related partitioning model, while OT-CEC adds complementary information about phospholipid composition and drug–membrane interactions.
-
Bestatin Hydrochloride: From Enzyme to Assay
2026-09-10
Bestatin hydrochloride (Ubenimex) is more than an aminopeptidase inhibitor: it is a mechanistic probe for connecting peptide processing with angiogenesis, tumor biology, and neuronal signaling. This guide explains how to interpret its phenotypes, design informative controls, and avoid confusing target engagement with downstream causality.
-
2-Hydroxypropyl-β-cyclodextrin Workflow Guide
2026-09-09
2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide used to improve handling of poorly water-soluble hydrophobic compounds, particularly molecules containing aromatic or phenyl groups. This guide covers formulation and biochemical workflows; it does not establish therapeutic efficacy, clinical bioavailability, or suitability for unrelated biological applications.
-
S Tag Peptide: Practical Fusion-Tag Workflow
2026-09-09
S Tag Peptide is a compact, highly soluble RNase A-derived peptide used to support recombinant protein detection, antibody-based capture, and protein solubility improvement. It is appropriate for aqueous handling and N- or C-terminal genetic fusions, but it should not be treated as a standalone ribonuclease, dissolved in ethanol, or stored as a long-term solution.
-
Cabozantinib: From Target Inhibition to Cell State
2026-09-08
Cabozantinib research is strengthened by separating direct kinase inhibition from time-dependent cellular adaptation. This article connects XL184 target engagement, phosphoproteomic remodeling, and RCC phenotypes to more interpretable assay design.
-
Matrine: From Cell Signals to Translation
2026-09-08
Matrine is moving from broad anticancer and anti-inflammatory claims toward a testable translational framework. Recent thymoma data connect Matrine with reduced stemness, apoptosis, YTHDF1, and Wnt/β-catenin signaling while defining the validation steps needed before clinical interpretation.
-
7-Ethyl-10-hydroxycamptothecin: Assay Logic
2026-09-07
7-Ethyl-10-hydroxycamptothecin, also known as SN-38, is more than a topoisomerase I probe. This guide develops an evidence-aligned assay strategy that separates replication stress, cell-cycle arrest, apoptosis, and FUBP1/FUSE pathway effects in advanced cancer research.